Literature DB >> 19253490

Health system and equity perspectives in health technology assessment.

Piya Hanvoravongchai1.   

Abstract

Economic evaluation is a useful and increasingly popular tool that helps policy makers and health practitioners in the assessment of new technology and health interventions. It is expected that careful assessment of the costs and benefits of all technology choices will guide one's decision in selecting the best mixture of cost-effective options, thus promoting allocative efficiency and increasing value for money within the limited resources available. The use of economic evaluation is also seen as a key step towards evidence-based medicine and evidence-based policy-making. Nevertheless, value for money and allocative efficiency may not be the only or the most important issue to be considered in technology adoption. There are a number of factors that should be evaluated in addition to economic efficiency These include safety, efficacy, and effectiveness of the technology or policy of interest. In addition, it is important to assess other external factors that could be impacted by the use of such technology or policy. This article presents two important areas of health technology assessment, in addition to economic evaluation, that must be considered as a part of any health technology assessment exercise. They are (1) health system feasibility and impact analysis, and (2) equity and fairness assessment.

Mesh:

Year:  2008        PMID: 19253490

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  6 in total

Review 1.  How contexts and issues influence the use of policy-relevant research syntheses: a critical interpretive synthesis.

Authors:  Kaelan A Moat; John N Lavis; Julia Abelson
Journal:  Milbank Q       Date:  2013-09       Impact factor: 4.911

Review 2.  Strengthening cost-effectiveness analysis in Thailand through the establishment of the health intervention and technology assessment program.

Authors:  Sripen Tantivess; Yot Teerawattananon; Anne Mills
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

3.  Multi-criteria decision analysis of breast cancer control in low- and middle- income countries: development of a rating tool for policy makers.

Authors:  Kristie Venhorst; Sten G Zelle; Noor Tromp; Jeremy A Lauer
Journal:  Cost Eff Resour Alloc       Date:  2014-05-17

Review 4.  Accounting for equity considerations in cost-effectiveness analysis: a systematic review of rotavirus vaccine in low- and middle-income countries.

Authors:  Marie-Anne Boujaoude; Andrew J Mirelman; Kim Dalziel; Natalie Carvalho
Journal:  Cost Eff Resour Alloc       Date:  2018-05-18

5.  Health technology assessment and priority setting for universal health coverage: a qualitative study of stakeholders' capacity, needs, policy areas of demand and perspectives in Nigeria.

Authors:  Benjamin S C Uzochukwu; Chinyere Okeke; Niki O'Brien; Francis Ruiz; Issiaka Sombie; Samantha Hollingworth
Journal:  Global Health       Date:  2020-07-08       Impact factor: 4.185

6.  Economic evaluation for first-line anti-hypertensive medicines: applications for the Philippines.

Authors:  Lester Sam Araneta Geroy
Journal:  Cost Eff Resour Alloc       Date:  2012-12-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.